Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Gorovits

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
The AAPS Journal|April 13, 2019
Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXa<sup>I16L</sup> in Preclinical SpeciesChuenlei Parng, Michael Bolt, Debra D Pittman, et al.
The AAPS Journal|April 2, 2013
Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulationMarian Kelley, Ago B Ahene, Boris Gorovits, et al.
The AAPS Journal|November 8, 2018
Approaches to Resolve False Reporting in Neutralizing Antibody Assays Caused by Reagent Leaching from Affinity Capture Elution Solid PhaseYuhong Xiang, John Kamerud, Jean Donley, et al.
The AAPS Journal|November 19, 2013
Large molecule specific assay operation: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamLauren Stevenson, Marian Kelley, Boris Gorovits, et al.
The AAPS Journal|October 25, 2017
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation StrategiesZhandong Don Zhong, Adrienne Clements-Egan, Boris Gorovits, et al.
The AAPS Journal|March 31, 2019
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal AntibodyYuhong Xiang, Chuenlei Parng, Katrina Olson, et al.
The AAPS Journal|January 5, 2020
Criteria to Reevaluate Anti-drug Antibody Assay Cut Point Suitability in the Target PopulationCharles Y Tan, Gregory S Steeno, Zhiping You, et al.
The AAPS Journal|April 18, 2019
Report on the AAPS Immunogenicity Guidance ForumHeather Myler, Boris Gorovits, Kelli Phillips, et al.
Pharmaceutical Research|May 13, 2021
Application of blood microsampling in cynomolgus monkey and demonstration of equivalent monoclonal antibody PK parameters compared to conventional samplingYing Wang, Sarah J Crowell, Alison Joyce, et al.
Bioanalysis|May 7, 2013
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paperBoris Gorovits, Stephen C Alley, Sanela Bilic, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
The AAPS Journal|April 13, 2019
Induction and Impact of Anti-Drug Responses Elicited by a Human Recombinant Coagulation Factor FXa<sup>I16L</sup> in Preclinical SpeciesChuenlei Parng, Michael Bolt, Debra D Pittman, et al.
The AAPS Journal|April 2, 2013
Theoretical considerations and practical approaches to address the effect of anti-drug antibody (ADA) on quantification of biotherapeutics in circulationMarian Kelley, Ago B Ahene, Boris Gorovits, et al.
The AAPS Journal|November 8, 2018
Approaches to Resolve False Reporting in Neutralizing Antibody Assays Caused by Reagent Leaching from Affinity Capture Elution Solid PhaseYuhong Xiang, John Kamerud, Jean Donley, et al.
The AAPS Journal|November 19, 2013
Large molecule specific assay operation: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization teamLauren Stevenson, Marian Kelley, Boris Gorovits, et al.
The AAPS Journal|October 25, 2017
Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation StrategiesZhandong Don Zhong, Adrienne Clements-Egan, Boris Gorovits, et al.
The AAPS Journal|March 31, 2019
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal AntibodyYuhong Xiang, Chuenlei Parng, Katrina Olson, et al.
The AAPS Journal|January 5, 2020
Criteria to Reevaluate Anti-drug Antibody Assay Cut Point Suitability in the Target PopulationCharles Y Tan, Gregory S Steeno, Zhiping You, et al.
The AAPS Journal|April 18, 2019
Report on the AAPS Immunogenicity Guidance ForumHeather Myler, Boris Gorovits, Kelli Phillips, et al.
Pharmaceutical Research|May 13, 2021
Application of blood microsampling in cynomolgus monkey and demonstration of equivalent monoclonal antibody PK parameters compared to conventional samplingYing Wang, Sarah J Crowell, Alison Joyce, et al.
Bioanalysis|May 7, 2013
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paperBoris Gorovits, Stephen C Alley, Sanela Bilic, et al.
Pageof 8